Faculty of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan.
Faculty of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan.
Clin Chim Acta. 2014 Feb 15;429:123-8. doi: 10.1016/j.cca.2013.11.027. Epub 2013 Dec 1.
Cytosine in urine is one of the biomarkers for the diagnosis of metabolic immunodeficiency. It has been mentioned that a high level of cytosine is found in urine of children having immunodeficiency. In this study, we have developed a fluorescence (fluorescence) derivatization reaction of cytosine using 4-trifluoromethylbenzamidoxime (4-TFMBAO) as a fluorogenic reagent.
In this reaction, cytosine was mixed with 4-TFMBAO, K3[Fe(CN)6], N,N-dimethylformamide (DMF) and KOH in an aqueous solution. The mixture was heated at 100°C for 20 min. The fluorescence intensity of the mixture was measured with a spectrofluorometer.
Under the optimized reaction conditions, a strong fluorescence was produced only from cytosine amongst 62 compounds including structurally related bio-substances. The selectivity and sensitivity of this method were compared with a conventional fluorescence one using 2-bromoacetophenone that reacts with cytosine, adenine and their related substances. The present method was sufficiently selective toward cytosine, and approximately 50 times more sensitive than the conventional one.
Our method permitted the quantitative determination of cytosine in human urines without any pretreatment for a primary screening test of inborn disorder in pyrimidine metabolism with immunodeficiency, and indicated the lower detection limit of 0.1 μmol/l cytosine which gave 3 times greater fluorescence intensity than that observed for the reagent blank.
尿嘧啶是诊断代谢免疫缺陷的生物标志物之一。有研究提到,免疫缺陷儿童的尿液中存在高水平的尿嘧啶。在这项研究中,我们开发了一种使用 4-三氟甲基苯甲肟(4-TFMBAO)作为荧光试剂的尿嘧啶荧光(荧光)衍生化反应。
在该反应中,将尿嘧啶与 4-TFMBAO、K3[Fe(CN)6]、N,N-二甲基甲酰胺(DMF)和 KOH 在水溶液中混合。将混合物在 100°C 下加热 20 分钟。用荧光分光光度计测量混合物的荧光强度。
在优化的反应条件下,只有尿嘧啶在 62 种化合物中产生了强烈的荧光,包括结构相关的生物物质。与使用与尿嘧啶、腺嘌呤及其相关物质反应的 2-溴苯乙酮的传统荧光法相比,该方法的选择性和灵敏度进行了比较。该方法对尿嘧啶具有足够的选择性,灵敏度比传统方法高约 50 倍。
我们的方法允许在无需任何预处理的情况下定量测定人尿中的尿嘧啶,用于免疫缺陷嘧啶代谢先天障碍的初步筛选试验,并表明检测下限为 0.1 μmol/l 尿嘧啶,其荧光强度比试剂空白观察到的高 3 倍。